ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MYO vs COCH // EV/EBITDA & P/E VALUATION

Myomo Inc. (NYSE) VS. Envoy Medical Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: MYO 7 — COCH 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MYO VS. COCH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MYO COCH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 65.70% -30.00% +95.70 MYO /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -35.20% -60.00% +24.80 MYO /operating-margins <GO>
Net Profit Margin -38.10% -60.00% +21.90 MYO /net-margins <GO>
Revenue Growth (YoY) 25.70% 7.10% +18.60 MYO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 3.62% -3.62 COCH /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 MYO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 61.5 50.8 +10.71 MYO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $51.5M $50.3M $1.2M MYO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MYO REV COCH REV MYO GROSS % COCH GROSS % MYO FCF COCH FCF
FY 2025 $40.9M $241.0K 65.7% -50.0% -$16.3M -$18.4M
FY 2024 $32.6M $225.0K 71.2% -50.0% -$4.7M -$18.9M
FY 2023 $19.2M $316.0K — — -$6.2M -$17.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MYO // BETA —
COCH // BETA —